-
2018 set benchmark for digital health investment – report
pharmaphorum
January 09, 2019
Last year was the biggest ever for digital health investment, according to a report that has been tracking the market since the beginning of the decade.
-
Bruntwood to make ￡10M life science investment
pharmatimes
December 20, 2018
Bruntwood SciTech has announced a ￡10 million investment into the life sciences sector, in the form of?50,000 square feet of office space and laboratory facilities in Alderley Park, Cheshire.
-
AI pathology project awarded ￡10.1m government funding
pharmaphorum
December 13, 2018
A digital pathology and artificial intelligence collaboration, with partners including Roche Diagnostics and Microsoft, has been awarded ￡10.1 million from a government-backed agency to expand across the north of England.
-
UCB to invest ￡1bn in the UK Life Sciences Sector Deal
pharmaceutical-technology
December 06, 2018
Belgian biopharmaceutical company UCB has agreed to invest approximately ￡1bn ($1.27bn) as part of a collaboration between the UK government and life sciences industry intended to support healthcare innovation in the country......
-
Strides board approves $15 m investment in Stelis Biopharma
expressbpd
November 24, 2018
The first close of the current fund raise is $35 million, of which Strides will commit $15 million and $20 million is from other existing shareholders
-
ADC Bio Secures ￡2.5M Investment
contractpharma
November 19, 2018
ADC Biotechnology(ADC Bio), announces that it has secured additional funding of 2.5 million from existing investors and
-
LANXESS to strengthen its Indian production sites
expressbpd
November 17, 2018
Specialty chemicals company LANXESS is strengthening its asset base in India. The company plans to invest up to ? 1250 crores till 2023. Focus areas of the investment will be the businesses for chemical intermediates, high-performance plastics and water t
-
LANXESS to strengthen its Indian production sites
expressbpd
November 17, 2018
Specialty chemicals company LANXESS is strengthening its asset base in India. The company plans to invest up to ? 1250 crores till 2023. Focus areas of the investment will be the businesses for chemical intermediates, high-performance plastics and water t
-
TraceLink $93 million investment to accelerate expansion of information-sharing network platform
cphi-online
August 23, 2018
Investment will fuel the digitalization of the global pharmaceutical supply chain through the integration of real-time information-sharing, to create a highly predictable supply chain for the industry.
-
Legend Capital co-invests $293M in Chinese DMC
biospectrumasia
August 03, 2018
Chinese Diagnostics Medical Corporation specializes in the design and development of diagnostic testing reagents.
ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
Pharma Sources Insight July 2025
